Registration for a live webinar on 'Precision medicine treatment for anticancer drug resistance' is now open.
See webinar detailsWe noted you are experiencing viewing problems
-
Check with your IT department that JWPlatform, JWPlayer and Amazon AWS & CloudFront are not being blocked by your network. The relevant domains are *.jwplatform.com, *.jwpsrv.com, *.jwpcdn.com, jwpltx.com, jwpsrv.a.ssl.fastly.net, *.amazonaws.com and *.cloudfront.net. The relevant ports are 80 and 443.
-
Check the following talk links to see which ones work correctly:
Auto Mode
HTTP Progressive Download Send us your results from the above test links at access@hstalks.com and we will contact you with further advice on troubleshooting your viewing problems. -
No luck yet? More tips for troubleshooting viewing issues
-
Contact HST Support access@hstalks.com
-
Please review our troubleshooting guide for tips and advice on resolving your viewing problems.
-
For additional help, please don't hesitate to contact HST support access@hstalks.com
We hope you have enjoyed this limited-length demo
This is a limited length demo talk; you may
login or
review methods of
obtaining more access.
Printable Handouts
Navigable Slide Index
- Introduction
- Table of contents
- Introduction to the theme
- No-property-principle
- The bundle theory of property
- European convention on human rights and biomedicine (Oviedo 1997)
- Commodification of body material
- Damage by loss of biomaterial
- Double character of body material
- Anonymisation and pseudonymisation of body material and accompanying data
- Declaration of Taipei: health databases and biobanks (World Medical Association 2016)
- Conclusions for practice I
- Conclusions for practice II
- Literature
- Thank you!
Topics Covered
- Regulation of tissue research
- No-Property-Principle
- The Bundle Theory of Property
- European Convention on Human Rights and Biomedicine
- Commodification of Body Material
- Damage by Loss of Material
- Double Character of Body Material
- Anonymisation and Pseudonymisation of Body Material
Talk Citation
Lenk, C. (2022, March 30). The legal and ethical framework for international tissue transfer [Video file]. In The Biomedical & Life Sciences Collection, Henry Stewart Talks. Retrieved December 22, 2024, from https://doi.org/10.69645/FXQP2177.Export Citation (RIS)
Publication History
Financial Disclosures
- Prof. Dr. Christian Lenk has not informed HSTalks of any commercial/financial relationship that it is appropriate to disclose.
Other Talks in the Series: Tissue in Research
Transcript
Please wait while the transcript is being prepared...
0:00
Dear audience, it is a
pleasure for me today
to give you the presentation on the ethical and
legal framework for international tissue transfer.
My name is Dr. Christian
Lenk and I'm a professor of
medical ethics at the
Institute for the History,
Theory and Ethics of Medicine
at Ulm University in Germany.
0:24
To come now to the first slide,
the table of contents
you see here.
Firstly, there will be
a short introduction
into the theme for you.
Then afterwards, I will go to
the so-called no-property
principle and
the bundle theory of property
regarding human tissue.
There are also some important
conventions in this field.
For example, the European Convention
on Human Rights and Biomedicine,
and further on we will deal with
commodification of body material,
and also question whether it is a
damage by loss of such material.
Further on, we also treat the so-called
double character of body material,
and the anonymisation and
pseudonormalisation of body material,
mainly as measurements for privacy
and confidentiality in medicine.
Another important declaration
and document, number nine,
is the Declaration of Taipei from
the World Medical Association,
which is on health
databases and biobanks.
Finally, I will draw some conclusions
for practice and present the literature
To give you a short
introduction into the scene,